Global Biological Therapies for Cancer Market 2022-2028

The global biological therapies for cancer market is expected to increase by USD 50 billion, at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2028, according to the latest edition of the Global Biological Therapies for Cancer Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biological therapies for cancer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biological therapies for cancer industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for biological therapies for cancer can be segmented By product CAR T-cell therapies, monoclonal antibodies, vaccines. The monoclonal antibodies segment held the largest share of the global biological therapies for cancer market in 2021 and is anticipated to hold its share during the forecast period. Biological therapies for cancer market is further segmented By region: Asia Pacific, Europe, North America, Rest of the World (RoW). Globally, North America made up the largest share of the biological therapies for cancer market.

By product:
- CAR T-cell therapies
- monoclonal antibodies
- vaccines

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The report also provides a detailed analysis of several leading biological therapies for cancer market vendors that include Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb Company (BMS), Eli Lilly and Company, F. Hoffmann-La Roche AG, Genmab A/S, Gilead Sciences, Inc., GlaxoSmithKline plc (GSK), Janssen Pharmaceuticals, Inc., Merck KGaA, Novartis International AG, Pfizer Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global biological therapies for cancer market.
- To classify and forecast the global biological therapies for cancer market based on product, region.
- To identify drivers and challenges for the global biological therapies for cancer market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biological therapies for cancer market.
- To identify and analyze the profile of leading players operating in the global biological therapies for cancer market.

Why Choose This Report
- Gain a reliable outlook of the global biological therapies for cancer market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
CAR T-cell therapies
Monoclonal antibodies
Vaccines
PART 6. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 7. KEY COMPANIES
Amgen Inc.
AstraZeneca plc
Bristol-Myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche AG
Genmab A/S
Gilead Sciences, Inc.
GlaxoSmithKline plc (GSK)
Janssen Pharmaceuticals, Inc.
Merck KGaA
Novartis International AG
Pfizer Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Global Microbiological Culture Market 2022 - Industry Briefing

The global microbiological culture market was valued at USD 1,896 million in 2021 to USD 2,537 million by 2028, progressing at a CAGR of 4.2% from 2022 to 2028.This industry

USD 600 View Report

Global High Content Screening Market 2022-2028

According to market research study published by Gen Consulting Company, the global high content screening market stood at around USD 1,105 million in 2021 and is projected to rise to

USD 2600 View Report

Global Biological Safety Testing Market 2022 - Snapshot

According to market research study published by Gen Consulting Company, the market size of the global biological safety testing sector is expected to rise by USD 14 billion with a

USD 1250 View Report

Global Biological Imaging Reagents Market Research Report 2021-2025

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Biological Imaging Reagents Report by Material, Application, and

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available